Today
Diagnosis and Management of Cutaneous Melanoma
The incidence and prevalence of cutaneous melanoma in the US and worldwide have increased over the last 5 decades. JAMA Review Author John Kirkwood, MD, discusses the epidemiology, risk factors, treatment, and prevention of melanoma with JAMA Deputy Editor Kristin Walter, MD, MS. ... Show More
22m 49s
Aug 18
Diagnosis and Treatment of Hemorrhoidal Disease
Hemorrhoidal disease, pathology of the tissue lining the anal canal, affects approximately 10 million individuals in the US. Author Jean H. Ashburn, MD, of Wake Forest University School of Medicine and JAMA Senior Editor Karen E. Lasser, MD, MPH, discuss the current evidence on t ... Show More
18m 40s
Aug 13
Treatment of Complicated Staphylococcus aureus Bacteremia
Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS ra ... Show More
11m 35s
Jul 23
122 | How to Support Patients on Obesity Medications: A Short Course on Side Effects, Satiety & Supplements
Join The Obesity Medicine Nutrition Course! Enter code POD15 at checkout for 15% off!Anti-obesity medications are everywhere—but they also come with new challenges. From rapid weight loss and side effects to TikTok-fueled supplement questions, patients on weight management medica ... Show More
29m 21s
Oct 2024
#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter In this “Ask Me Anything” (AMA) episode, Peter dives back into the increasingly popular topic of GLP-1 agonists, such as Ozempic and Mounjaro, which ... Show More
20m 36s
Oct 2024
#537: Appetite Regulation, Metabolic Compensation and More – Stephan Guyenet, PhD
This is an “ask me anything” (AMA) episode with Dr. Stephan Guyenet, an expert in obesity neuroscience and eating behavior. This episode was originally published on Sigma Nutrition Premium. If you’re interested in subscribing to Sigma Nutrition Premium, then check all the details ... Show More
1h 4m
Jul 2024
Tara Swart (Neuroscientist): The Science Behind Stress, Body Fat & Manifestation (E273)
In this episode, respected neuroscientist and author Dr. Tara Swart joins Jake to uncover fascinating perspectives about the complex interplay between our brains and bodies.
Tara sheds light on how our constant smartphone use impacts us both mentally and physically, and what we c ... Show More
56m 42s
Dec 2024
How Ozempic Transformed the Way We Look at Obesity
Ozempic, Wegovy, and Mounjaro, are being called “miracle drugs” with users boasting about their fast results. Dr. Sanjay Gupta takes a deep dive into how they disrupted the entire weight loss industry and changed the conversation about obesity. Learn more about your ad choices. ... Show More
25m 47s
May 2024
#323: The Hidden Risks of Weight-Loss Drugs: Behind the GLP-1 Hype with Ragen Chastain
Writer, speaker, and weight-inclusive health/fitness professional Ragen Chastain joins us to discuss the potential side effects and other downsides of using GLP-1 drugs (like Ozempic and its ilk) for weight loss, the massive influence the manufacturers of these drugs are having o ... Show More
38m 49s
Mar 2024
Is obesity a choice?
Globally, 650 million people meet the threshold for obesity. With those numbers on the rise, we ask: Is obesity a matter of individual choice, or is it rooted in larger systemic problems? Greg Doucette, a bodybuilder and health coach, says that obesity is a choice, and argues tha ... Show More
31m 56s